Avalo Therapeutics Executives Sell Shares, Buy Others Amid Market Volatility

Avalo Therapeutics, Inc. (AVTX) has disclosed several transactions involving its top executives. On April 1, 2026, Chief Medical Officer Doyle Mittie sold 679 shares at $16 per share and subsequently purchased 679 shares at $8.04 per share. Additionally, Chief Financial Officer Sullivan Christopher Ryan sold 500 shares at $15.86 per share, as well as 7,479 shares at $16.83 per share and 6,200 shares at $17.02 per share on the same day. On April 2, 2026, Ryan also sold 1,780 shares at $17.57 per share. These transactions are subject to regulatory scrutiny and may be of interest to investors and analysts following the company's performance.